Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Olfactory Outcomes With Dupilumab in Chronic Rhinosinusitis With Nasal Polyps
Joaquim Mullol, Claus Bachert, Nikhil Amin, et al.
The Journal of Allergy and Clinical Immunology In Practice (2021) Vol. 10, Iss. 4, pp. 1086-1095.e5
Open Access | Times Cited: 74

Showing 1-25 of 74 citing articles:

EPOS/EUFOREA update on indication and evaluation of Biologics in Chronic Rhinosinusitis with Nasal Polyps 2023
W.J. Fokkens, A-S Viskens, V. Backer, et al.
Rhinology Journal (2023)
Open Access | Times Cited: 157
Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP): A multicentric observational Phase IV real‐life study (DUPIREAL)
Eugenio De Corso, Ernesto Pasquini, Matteo Trimarchi, et al.
Allergy (2023) Vol. 78, Iss. 10, pp. 2669-2683
Open Access | Times Cited: 77
The interleukin-4/interleukin-13 pathway in type 2 inflammation in chronic rhinosinusitis with nasal polyps
Claus Bachert, Alexandra Hicks, Simon Gane, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 16
Neuroimmune interplay during type 2 inflammation: Symptoms, mechanisms, and therapeutic targets in atopic diseases
Brian Kim, Marc E. Rothenberg, Xin Sun, et al.
Journal of Allergy and Clinical Immunology (2023) Vol. 153, Iss. 4, pp. 879-893
Open Access | Times Cited: 35
Olfactory dysfunction: etiology, diagnosis, and treatment
Thomas Hummel, David T. Liu, Christian A. Müller, et al.
Deutsches Ärzteblatt international (2023)
Open Access | Times Cited: 28
Biologic treatment for severe chronic rhinosinusitis with nasal polyps: a systematic review and meta-analysis
Harsha H. Kariyawasam, Deepak P. Chandrasekharan, T Jacques, et al.
Rhinology Journal (2023) Vol. 61, Iss. 2, pp. 98-107
Open Access | Times Cited: 26
Real-world evidence for the effectiveness and safety of dupilumab in patients with CRSwNP after 1 year of therapy
Tobias Albrecht, Martin M. Sailer, Flavia Capitani, et al.
World Allergy Organization Journal (2023) Vol. 16, Iss. 5, pp. 100780-100780
Open Access | Times Cited: 23
Switching of biological therapy to dupilumab in comorbid patients with severe asthma and CRSwNP
Cecilia Rosso, Eugenio De Corso, Valerio Conti, et al.
European Archives of Oto-Rhino-Laryngology (2024) Vol. 281, Iss. 6, pp. 3017-3023
Open Access | Times Cited: 12
Effect of Dupilumab in CRSwNP Sinonasal Outcomes from Real Life Studies: A Systematic Review with Meta-analysis
Miguel Rodriguez-Iglesias, Christian Calvo‐Henríquez, Daniel Martín-Jiménez, et al.
Current Allergy and Asthma Reports (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Early clinical improvement of anosmia and sinus nitric oxide in chronic rhinosinusitis with nasal polyps subjects treated with dupilumab
Miguel J. Lanz, C. Eisenlohr, Lianet Herrera Cepeda
Allergy and Asthma Proceedings (2025) Vol. 46, Iss. 2, pp. 105-108
Closed Access | Times Cited: 1
Olfaction Recovery following Dupilumab Is Independent of Nasal Polyp Reduction in CRSwNP
Elena Cantone, Eugenio De Corso, Filippo Ricciardiello, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 8, pp. 1215-1215
Open Access | Times Cited: 35
Chronic rhinosinusitis with nasal polyps (CRSwNP) treated with omalizumab, dupilumab, or mepolizumab: A systematic review of the current knowledge towards an attempt to compare agents’ efficacy
George Papacharalampous, Jannis Constantinidis, G. Fotiadis, et al.
International Forum of Allergy & Rhinology (2023) Vol. 14, Iss. 1, pp. 96-109
Open Access | Times Cited: 21
Sense of smell in chronic rhinosinusitis: A multicentric study on 811 patients
Alberto Macchi, Alessia Giorli, Elena Cantone, et al.
Frontiers in Allergy (2023) Vol. 4
Open Access | Times Cited: 20
Dupilumab in chronic rhinosinusitis with nasal polyps: Real life data in a multicentric Sicilian experience
Cosimo Galletti, Martina Ragusa, Federico Sireci, et al.
American Journal of Otolaryngology (2023) Vol. 45, Iss. 1, pp. 104106-104106
Open Access | Times Cited: 19
Biologics for Chronic Rhinosinusitis—A Modern Option for Therapy
Romică Cergan, Ovidiu Berghi, Mihai Dumitru, et al.
Life (2023) Vol. 13, Iss. 11, pp. 2165-2165
Open Access | Times Cited: 19
Interpretation of Clinical Efficacy of Biologics in Chronic Rhinosinusitis With Nasal Polyps via Understanding the Local and Systemic Pathomechanisms
Seung Koo Yang, Seong Cho, Dae Woo Kim
Allergy Asthma and Immunology Research (2022) Vol. 14, Iss. 5, pp. 465-465
Open Access | Times Cited: 25
Prevalence of type 2 inflammatory signatures and efficacy of dupilumab in patients with chronic rhinosinusitis with nasal polyps from two phase 3 clinical trials: SINUS‐24 and SINUS‐52
Claus Bachert, Asif Khan, Stella E. Lee, et al.
International Forum of Allergy & Rhinology (2023) Vol. 14, Iss. 3, pp. 668-678
Open Access | Times Cited: 14
Olfaction Now and in the Future in CRSwNP
Hannan A. Qureshi, Andrew P. Lane
American Journal of Rhinology and Allergy (2023) Vol. 37, Iss. 2, pp. 168-174
Closed Access | Times Cited: 13
Effectiveness and rapidity on olfatory fuction recovery in CRS patients treated with Dupilumab: a real life prospective controlled study
Ignazio La Mantia, Egle Grigaliute, Martina Ragusa, et al.
European Archives of Oto-Rhino-Laryngology (2023) Vol. 281, Iss. 1, pp. 219-226
Closed Access | Times Cited: 13
Brazilian guideline for the use of immunobiologicals in chronic rhinosinusitis with nasal polyps ‒ 2024 update
Wilma Terezinha Anselmo‐Lima, Fabrizio Ricci Romano, Edwin Tamashiro, et al.
Brazilian Journal of Otorhinolaryngology (2024) Vol. 90, Iss. 3, pp. 101394-101394
Open Access | Times Cited: 5
Efficacy of dupilumab in real-life settings: a STROBE study
A. Gal, R. Gravier-Dumonceau, M. Pénicaud, et al.
European Archives of Oto-Rhino-Laryngology (2024) Vol. 281, Iss. 9, pp. 4781-4788
Closed Access | Times Cited: 5
Therapies for Olfactory Dysfunction — an Update
Aria Jafari, Eric H. Holbrook
Current Allergy and Asthma Reports (2022) Vol. 22, Iss. 3, pp. 21-28
Open Access | Times Cited: 22
Dupilumab increases aspirin tolerance in NSAID-exacerbated respiratory disease
Sven Schneider, Katharina Poglitsch, Christina Morgenstern, et al.
European Respiratory Journal (2022) Vol. 61, Iss. 3, pp. 2201335-2201335
Open Access | Times Cited: 21
Targeting IL-4 and IL-13 Receptors on Eosinophils in CRSwNP Patients: The Clinical Efficacy of Dupilumab
Giovanna Piazzetta, Nadia Lobello, Emanuela Chiarella, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 9, pp. 1404-1404
Open Access | Times Cited: 12
A Decade of Clinical Advances in Chronic Rhinosinusitis: 2012–2022
Robert M. Naclerio, Joaquim Mullol, Whitney W. Stevens
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 1, pp. 43-50
Closed Access | Times Cited: 11
Page 1 - Next Page

Scroll to top